Figure 4.

(a, b) Relative viability of MG-63 and HUVECs incubated with a series of gradient concentrations of hr-CDs for 24 h. Cytotoxicity was evaluated by flow cytometry using (c) MG-63 cells and (d) HUVECs treated with hr-CDs (50 μg/mL) for 72 h.